X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUG RESISTANCE UPDATES

期刊標題檢索 DRUG RESIST UPD 最新評論: It is indeed too slow. If you are in a hurry to graduate or in a hurry... (2024-09-03)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUG RESISTANCE UPDATES]您好,您是該頁面的第 44401 位訪客。

期刊簡介
期刊名稱DRUG RESISTANCE UPDATES DRUG RESISTANCE UPDATES
LetPub Score
9.2
50 ratings
Rate

Reputation
10.0

Influence
8.5

Speed
9.6

期刊簡稱DRUG RESIST UPDATE
ISSN1368-7646
E-ISSN1532-2084
h-index100
CiteScore
CiteScoreSJRSNIPCiteScore Rank
26.204.6652.998
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q11 / 272
Category: Medicine
Subcategory: Pharmacology
Q15 / 313
Category: Medicine
Subcategory: Infectious Diseases
Q110 / 344
Category: Medicine
Subcategory: Oncology
Q115 / 404
Category: Medicine
Subcategory: Cancer Research
Q112 / 230

自引率 (2023-2024)4.40%自引率趨勢
掲載範囲
Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.

It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.

Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.

*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease
*Describes emerging technologies and therapies, particularly those that overcome drug resistance
*Emphasises common themes in microbial and cancer research
官方網站http://www.journals.elsevier.com/drug-resistance-updates/
在線稿件提交
開放訪問No
出版商Churchill Livingstone
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1998
每年文章數72每年文章數趨勢
黃金OA百分比40.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ13/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1368-7646%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Invited contributions ? Irregular
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【DRUG RESISTANCE UPDATES】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    PHYTOMEDICINEH-index: 105

    CiteScore: 10.30
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY499207
    PHYTOMEDICINE347163
    LIFE SCIENCES295205
    PHARMACOLOGICAL RESEARCH246312
    International Journal of Pharmaceutics243133
    European Journal of Pharmacology205387
    BIOCHEMICAL PHARMACOLOGY203402
    JOURNAL OF NATURAL PRODUCTS197024
    BRITISH JOURNAL OF PHARMACOLOGY165849
    MOLECULAR PHARMACEUTICS163138
  •  

    DRUG RESISTANCE UPDATES DRUG RESISTANCE UPDATES
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [DRUG RESISTANCE UPDATES] 的評論撰寫評論
作者: zxmine


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2024-09-03 18:56:23 評論於
It is indeed too slow. If you are in a hurry to graduate or in a hurry to use it, please invest cautiously.
(0) 讚! | zxmine

作者: Tomorrow's sun


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-06 15:36:15 評論於
Tumor, a top journal on microbial drug resistance, medical field, very professional, accepts reviews and innovative research articles, very promising.
(1) 讚! | Tomorrow's sun

作者: 白云曼萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-06 09:27:53 評論於
So slow!!!
(0) 讚! | 白云曼萱

作者: 削月会强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-01 10:09:22 評論於
Research focus: tumor drug resistance
Experience sharing: Too too too too too slow...
(0) 讚! | 削月会强

作者: 一条小海之


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-28 17:28:25 評論於
Research focus: Tumor drug resistance; Experience of drug resistance: Submitted in August of 23rd year, edited for 17 days, reviewed externally for 2 and a half months, major revision for 6 months, second review for 14 days, accepted in June of 24th year.
(0) 讚! | 一条小海之

作者: zxmine


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-24 15:22:03 評論於
Submitted in August 23rd, with editor for 2 weeks, it was extremely difficult to find experts for external review. A total of 46 experts were invited, with 2 rounds of review and 36 questions. Major revisions were made in November, with a 3-month extension. The revised manuscript was submitted by the end of May and received a second review in June, lasting 15 days. It has been accepted.
(0) 讚! | zxmine

作者: 绿松少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-03 14:05:22 評論於
Excuse me, is it an article or a review? And how many reviewers are there?
(0) 讚! | 绿松少女

作者: 削月会强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 20:13:00 評論於
Wow, this is taking too much time
(0) 讚! | 削月会强

作者: john888


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-15 15:05:35 評論於
Is it easy for senior experts to review submissions? Is it difficult to find reviewers?
(0) 讚! | john888

作者: 中原向雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-13 19:51:48 評論於
How are you doing?
(0) 讚! | 中原向雪

作者: 中原向雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-13 15:01:31 評論於
Did you not find the reviewer's rejection?
(0) 讚! | 中原向雪

作者: 中原向雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-11 13:57:52 評論於
Have you received this piece of drug article?
(0) 讚! | 中原向雪

作者: 削月以松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-04 17:04:51 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0  
Research focus: Antimicrobial resistance sharing experience: Previously a review journal so the impact factor is very high (>20) but the reputation is average. Starting to accept articles in 2023 (The overall quality of the articles is decent, but may not reach the top 20 level) The final stability level is still to be observed. There are suitable articles. Why not try submitting one?
(0) 讚! | 削月以松

作者: Tomorrow's sun


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-01-17 14:38:44 評論於
The latest partition in 2024 is not from a top journal, which is indeed confusing. What's the point of changing it back and forth?
(0) 讚! | Tomorrow's sun

作者: 破戒淑琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-11 13:44:03 評論於
How long will it take to meet with the editor later?
(0) 讚! | 破戒淑琴

作者: 破戒淑琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-09 22:58:00 評論於
Submission success rate: 25.0
Research focus: Microbial drug resistance
Sharing experience: Hey friends, how long does it take for this journal submission to reach the editor with edits?
(0) 讚! | 破戒淑琴

作者: 罗汉沈然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-30 15:50:25 評論於
Do you have any feedback on the manuscript?
(0) 讚! | 罗汉沈然

作者: 景焕小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-11 09:02:33 評論於
2-4 days
(0) 讚! | 景焕小姐姐

作者: 映真郎


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-10 20:00:32 評論於
Do you have a link?
(0) 讚! | 映真郎

作者: 金山静梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-10 10:49:03 評論於
In general, parents should listen to their children more, even if what the children are saying is not important
(0) 讚! | 金山静梅

作者: 金山静梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-08 13:13:25 評論於
Dr. Bik is reporting Chen Zhe Sheng's peer review fraud
(0) 讚! | 金山静梅

作者: 景焕小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-07 13:10:18 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Emphasized research direction: drug resistance 
Experience sharing: Record the process for reference: After submission, waited more than 20 days for the editor's handling, waited 2 months for external review, and waited 20 days for RRC and other editor's handling, then got rejected. The editor's processing efficiency is low, and it is difficult to find expert reviewers
(0) 讚! | 景焕小姐姐

作者: 金山静梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-06 14:35:13 評論於
Editor-in-chief Chen Zhesheng is currently being reported by Dr. Bik
(0) 讚! | 金山静梅

作者: 天池骊颖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-03 11:26:07 評論於
How long after "with editor" will it be sent for external review?
(0) 讚! | 天池骊颖

作者: 景焕小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-20 17:08:59 評論於
Uncertain, but it usually takes a long time to hear back from the editor, which indicates the risk of having the manuscript rejected at the initial review
(0) 讚! | 景焕小姐姐

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [DRUG RESISTANCE UPDATES] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*